Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

In a message to constituents, Congressman John Garamendi is taking issue with statements earlier this month by House Speaker Mike Johnson regarding wildfire relief funds for California in the wake ...

Educator Colleen Donovan is at the top of her game, preparing medical students for challenges they’ll face in their careers.

In a three-hour committee meeting on Wednesday, senators on the Health and Provider Services Committee revived some ...

Legislators voted to move five of the six bills forward in the legislative process, including bills banning non-compete ...

Analyst Tim Anderson of Bank of America Securities reiterated a Hold rating on Johnson & Johnson (JNJ – Research Report), reducing the ...

In a report released yesterday, Larry Biegelsen from Wells Fargo assigned a Hold rating on Johnson & Johnson (JNJ – Research Report), with ...

Valley Vital operates infusion therapy pharmacies across four regions in Virginia and West Virginia, offering comprehensive ...

The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...

In today's Health Alert, the FDA has approved the first stand-alone nasal spray to treat drug-resistant depression.

We recently published a list of Jim Cramer Discusses TikTok Ban, President Trump & These 6 Stocks. In this article, we are ...

Senators spent three hours wrestling with some familiar health care topics on Wednesday, including prior authorization and ...